Establishment of measles virus receptor-expressing Vero cells lacking functional poliovirus receptors.


Journal

Microbiology and immunology
ISSN: 1348-0421
Titre abrégé: Microbiol Immunol
Pays: Australia
ID NLM: 7703966

Informations de publication

Date de publication:
Mar 2023
Historique:
revised: 20 11 2022
received: 19 07 2022
accepted: 21 12 2022
pubmed: 24 12 2022
medline: 7 3 2023
entrez: 23 12 2022
Statut: ppublish

Résumé

Global efforts are underway to eliminate measles and rubella, and active viral surveillance is the key to achieving this goal. In addition, the World Health Organization announced guidelines for handling materials potentially infectious for poliovirus (PV) to minimize the risk of PV reintroduction and to achieve PV eradication. To support global efforts, we established new PV-non-susceptible cell lines that are useful for the isolation of measles virus (MeV) and rubella virus (RuV) (Vero ΔPVR1/2 hSLAM+). In the cell lines, MeV and RuV replicated efficiently, with no concern regarding PV replication.

Identifiants

pubmed: 36564197
doi: 10.1111/1348-0421.13047
doi:

Substances chimiques

poliovirus receptor 0
Receptors, Virus 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

166-170

Subventions

Organisme : World Health Organization
ID : 001
Pays : International
Organisme : Japan Agency for Medical Research and Development
ID : JP22fk0108628

Informations de copyright

© 2022 The Societies and John Wiley & Sons Australia, Ltd.

Références

WHO. Guidance to minimize risk for facilities collecting, handling, or sorting materials potentially infectious for polioviruses. 2018. Available from: https://polioeradication.org/wp-content/uploads/2018/06/polio-containment-guidance-for-non-poliovirus-facilities-20180614-en.pdf
Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000;406:893-7.
Koike S, Ise I, Sato Y, Yonekawa H, Gotoh O, Nomoto A. A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol. 1992;66:7059-66.
Okemoto-Nakamura Y, Someya K, Yamaji T, Saito K, Takeda M, Hanada K. Poliovirus-nonsusceptible Vero cell line for the World Health Organization global action plan. Sci Rep. 2021;11:6746.
Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol. 2001;75:4399-401.
WHO. Manual for the laboratory diagnosis of measles and rubella virus infection. 2nd ed. Geneva: WHO press; 2007.
Manukyan H, Zagorodnyaya T, Ruttimann R, et al. Quantitative multiplex one-step RT-PCR assay for identification and quantitation of Sabin strains of poliovirus in clinical and environmental specimens. J Virol Methods. 2018;259:74-80.
Hashimoto K, Ono N, Tatsuo H, et al. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol. 2002;76:6743-49.
Seki F, Someya K, Komase K, Takeda M. A chicken homologue of nectin-4 functions as a measles virus receptor. Vaccine. 2016;34:7-12.
Sakata M, Otsuki N, Okamoto K, et al. Short self-interacting N-terminal region of rubella virus capsid protein is essential for cooperative actions of capsid and nonstructural p150 proteins. J Virol. 2014;88:11187-98.
Benamar T, Tajounte L, Alla A, et al. Real-time PCR for measles virus detection on clinical specimens with negative IgM result in Morocco. PLoS One. 2016;11:e0147154.
Plumet S, Duprex WP, Gerlier D. Dynamics of viral RNA synthesis during measles virus infection. J Virol. 2005;79:6900-08.
Okamoto K, Mori Y, Komagome R, et al. Evaluation of sensitivity of TaqMan RT-PCR for rubella virus detection in clinical specimens. J Clin Virol. 2016;80:98-101.

Auteurs

Kenji Someya (K)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Global Specialized Laboratory for Measles and Rubella, The World Health Organization, Tokyo, Japan.

Yuko Okemoto-Nakamura (Y)

Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.

Takako Kurata (T)

Osaka Institute of Public Health, Osaka, Japan.

Daiki Kanbayashi (D)

Osaka Institute of Public Health, Osaka, Japan.

Noriko Saito (N)

Aichi Prefectural Institute of Public Health, Nagoya, Japan.

Masae Itamochi (M)

Toyama Institute of Health, Toyama, Japan.

Noriyuki Otsuki (N)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Global Specialized Laboratory for Measles and Rubella, The World Health Organization, Tokyo, Japan.

Kentaro Hanada (K)

Department of Quality Assurance and Radiological Protection, National Institute of Infectious Diseases, Tokyo, Japan.

Makoto Takeda (M)

Department of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Global Specialized Laboratory for Measles and Rubella, The World Health Organization, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH